Canada’s public health agency has reported an increase in antimicrobial-resistant gonococcal infections. Data on 3,377 gonorrhea cases revealed that over a span of 2 years, antimicrobial-resistant gonococcal infections increased while gonococcal cultures demonstrating resistance rose from 24.8% in 2020 to 44.5% in 2021. Resistance to ciprofloxacin was most prevalent, rising from 46.6% of cases in 2020 to 63.1% in 2021. More than 80% of the gonorrhea cases studied were among males, and 55.5% of those cases were men who have sex with men.
Advice for all: The authors say continuous monitoring is of paramount importance: “Gonorrhea treatment resistant to azithromycin and ceftriaxone are a global concern and have been reported in several countries worldwide.”